Invesco’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-40,409
| Closed | -$91.7K | – | 3872 |
|
|
2024
Q1 | $91.7K | Buy |
40,409
+27,677
| +217% | +$62.8K | ﹤0.01% | 3738 |
|
|
2023
Q4 | $37.3K | Buy |
12,732
+2,453
| +24% | +$7.19K | ﹤0.01% | 3765 |
|
|
2023
Q3 | $43.5K | Hold |
10,279
| – | – | ﹤0.01% | 3793 |
|
|
2023
Q2 | $90.1K | Buy |
+10,279
| New | +$90.1K | ﹤0.01% | 3730 |
|
|
2022
Q2 | – | Sell |
-3,590
| Closed | -$43K | – | 4018 |
|
|
2022
Q1 | $43K | Sell |
3,590
-4
| -0.1% | -$48 | ﹤0.01% | 3905 |
|
|
2021
Q4 | $59K | Sell |
3,594
-1,351
| -27% | -$22.2K | ﹤0.01% | 3928 |
|
|
2021
Q3 | $79K | Buy |
4,945
+1,301
| +36% | +$20.8K | ﹤0.01% | 3932 |
|
|
2021
Q2 | $337K | Buy |
+3,644
| New | +$337K | ﹤0.01% | 3553 |
|
|
2019
Q1 | – | Sell |
-882
| Closed | -$25K | – | 3663 |
|
|
2018
Q4 | $25K | Sell |
882
-27
| -3% | -$765 | ﹤0.01% | 3690 |
|
|
2018
Q3 | $39K | Sell |
909
-27
| -3% | -$1.16K | ﹤0.01% | 3778 |
|
|
2018
Q2 | $37K | Buy |
+936
| New | +$37K | ﹤0.01% | 3774 |
|